Financing, pricing, and utilization of pharmaceuticals in China : the road to reform policy (Vol. 1 of 2) : Executive summary (Chinese)

This paper examines the financing, pricing, and utilization of pharmaceuticals in China the pharmaceutical system as it has evolved, and some changes that would improve it in the context of the national health reform process. The present paper builds upon earlier critical reviews and other papers published in the series china health policy notes. The paper is divided into four parts. The first section provides an overview of the Chinese pharmaceutical...

Document also available in : English, Chinese, English

DETAILS

Author

Hu,Shanlian;
Document Date
2010/06/01
Document Type
Working Paper (Numbered Series)
Report Number
58410
Volume No
1
Total Volume(s)
2 (See all volumes)
Country
China,
Region
East Asia and Pacific,
Disclosure Date
2010/12/14
Disclosure Status
Disclosed
Doc Name
Executive summary
Keywords
accountability

Citation

Hu,Shanlian.

Financing, pricing, and utilization of pharmaceuticals in China : the road to reform policy (Vol. 1 of 2) : Executive summary (Chinese). China health policy notes ; no. 1 Washington, DC: World Bank. http://documents.worldbank.org/curated/en/147681468010854943

Financing, pricing, and utilization of pharmaceuticals in China : the road to reform policy (Vol. 1 of 2) : Executive summary (Chinese)

DETAILS

Citation

RELATED LINKS

SUBSCRIBE TO EMAIL ALERTS